DAFUR, S. J., & LAR, P. M. (2003). THE EFFECT OF SCHISTOSOMA MANSONI CERCARIA INFECTION AND TREATMENT WITH NIRIDAZOLE ON TESTICULAR HISTOLOGY OF THE MICE. African Journal of Clinical and Experimental Microbiology, 4(1), 2–5. https://doi.org/10.4314/ajcem.v4i1.7316
Copyright for articles published in this journal is retained by the journal.
Main Article Content
THE EFFECT OF SCHISTOSOMA MANSONI CERCARIA INFECTION AND TREATMENT WITH NIRIDAZOLE ON TESTICULAR HISTOLOGY OF THE MICE.
SYLVNUS JOSIAH DAFUR
PATRICIA MANKO LAR
Abstract
The testicular histology of mice infected with Schistosoma mansoni (S.mansoni) cercaria and treated with Niridazole was examined. The results reveal that infection of mice with Schistosoma mansoni cercariae resulted in distortion of the testicular cyto-architecture including disruption of spermatogenesis as shown by the absence of spermatozoa in the lumen of the sominiferous tubule and distruction of the inter-tubular connective tissue of the infected mice. These changes were reversed to normalcy following two-course treatment of the infected mice with Niridazole after five weeks.
(Af. J. of Clinical and Experimental Microbiology: 2003 4(1): 2-5)
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.